Signal Transduction Pathways in Eosinophil Priming
Signal Transduction Pathways in Eosinophil Priming
批准号:
7391415
负责人:
PAUL JOHN BERTICS
金额:
$38.78万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-12-01 至 2012-11-20
关键词:
AbbreviationsAdherenceAffectAllergicArrestinArrestinsAsthmaAttenuatedBindingBiologicalBiologyBloodCell CountCell SurvivalCell membraneCell surfaceCellsCharacteristicsChemotactic FactorsChemotaxisCholesterolComplexCytoplasmic GranulesDependenceDevelopmentDiseaseEnd PointEnvironmentEvaluationEventExhibitsExtrinsic asthmaFamilyFamily memberFibrosisFigs - dietaryG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGTP-Binding ProteinsGene ExpressionGenesGoalsGranulocyte-Macrophage Colony-Stimulating FactorHumanIndividualInflammationInflammatoryInterleukin-3Interleukin-5InvestigationJanus kinaseLeukotriene C4Leukotriene ProductionLigandsLinkLungMAPK1 geneMAPK3 geneMediatingMediator of activation proteinMembraneMembrane MicrodomainsMethodsMitogen-Activated Protein KinasesModelingMolecularNumbersPathogenesisPathway interactionsPatientsPeptidesPeripheralPositioning AttributePrincipal InvestigatorProcessProductionProtein KinaseProtein Tyrosine KinaseProteinsRANTESReagentReceptor SignalingRegulationResearchRoleSTAT proteinScaffolding ProteinSignal TransductionSignal Transduction PathwaySignaling MoleculeStimulusTestingTissuesWorkallergic airway inflammationarrestin3basebeta-arrestincell motilitycell typechemokineconceptcytokinecytotoxiceosinophilfMet-Leu-Phe receptorin vivomethionyl-leucyl-phenylalaninemigrationprogramsproto-oncogene protein pim-1responsetranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This proposal is focused on defining the cellular mechanisms that regulate key aspects of human eosnophil
biology, including cell sensitization (priming), chemotaxis, survival and proinflammatory/cytotoxic activities.
Eosinophil recruitment and activation are characteristic of airway disorders such as allergic disease, and
these cells exhibit multiple effector activities that contribute to the tissue damage and fibrosis associated with
asthma. In this regard, interleukin-5 (IL-5) and related cytokines are critical for modulating eosinophil
degranulation, migration, gene expression, and viability. Also, low levels of IL-5-family cytokines induce the
enhanced responsiveness of eosinophils to a variety of secondary agents, such as chemoattractants.
Although this priming process is important for eosinophil biology, the associated signaling events are not well
understood. However, we are uniquely positioned to carefully dissect the role of specific signaling events in
modulating blood and airway eosinophil function. Capabilities enabling this research include: a) Routine
access to large numbers of highly purified human blood and airway eosinophils. b) Our ongoing identification
of key signaling molecules mediating IL-5 and chemoattractant action in blood and airway eosinophils, e.g:,
Ras, the MAP kinases (ERKs 1 and 2), the transcriptional regulators STATs 3 and 5, the beta-arrestin
adaptor molecules, and the survival-associated kinase Pim-1. c) Our development of essential molecular and
pharmacological methods for analyzing cytokine/chemoattractant signaling in human eosinophils. These
abilities allow us to test the hypothesis that eosinophil regulation by IL-5 involves the aforementioned
signaling molecules, and that their regulation is important for priming blood eosinophils to become
responsive to chemoattractants. The following Aims are proposed: 1) Define the mechanisms of IL-5-
mediated priming of chemoattractant-induced events in human blood eosinophils using the activation of the
MAP kinases (ERK1/ ERK2) as a cellular marker. 2). Determine the biological relevance of IL-5-dependent
activation of specific receptor/signaling complexes (Ras/ERK, tyrosine kinases, Deta-arrestins) and the
integrity of membrane microdomains in the control of blood and airway eosinophil function. 3) Test the
concept that Jak-STAT-dependent pathways are linked to IL-5-mediated regulation of human eosinophil
priming and function, including Pim-1 expression,.cell survival and chemoattractant-induced responses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Signal Transduction Pathways in Eosinophil Priming
-
批准号:7843280
-
项目类别:
-
资助金额:$38.8万
-
财政年份:2009
-
负责人:PAUL JOHN BERTICS
-
依托单位:
Molecular Analysis Using Liquid Crystal Technology
-
批准号:7603015
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2007
-
负责人:PAUL JOHN BERTICS
-
依托单位:
Molecular Analysis Using Liquid Crystal Technology
-
批准号:7240191
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2007
-
负责人:PAUL JOHN BERTICS
-
依托单位:
Molecular Analysis Using Liquid Crystal Technology
-
批准号:7418290
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2007
-
负责人:PAUL JOHN BERTICS
-
依托单位:
Rhinovirus Stimulation of Macrophage Signaling /Mediator
-
批准号:7151330
-
项目类别:
-
资助金额:$17.18万
-
财政年份:2006
-
负责人:PAUL JOHN BERTICS
-
依托单位:
IL-5 receptor activation and eosinophil signal transduction
-
批准号:6565042
-
项目类别:
-
资助金额:$19.62万
-
财政年份:2002
-
负责人:PAUL JOHN BERTICS
-
依托单位:
IL-5 receptor activation and eosinophil signal transduction
-
批准号:6630927
-
项目类别:
-
资助金额:$19.62万
-
财政年份:2002
-
负责人:PAUL JOHN BERTICS
-
依托单位:
EFFECT OF INTERLEUKIN 5 RECEPTOR ACTIVATION ON EOSINOPHIL SIGNAL TRANSDUCTION
-
批准号:6410556
-
项目类别:
-
资助金额:$19.62万
-
财政年份:2000
-
负责人:PAUL JOHN BERTICS
-
依托单位:
IL 5 REGULATION OF EOSINOPHIL SIGNAL TRANSDUCTION AND FUNCTION
-
批准号:6340663
-
项目类别:
-
资助金额:$15.45万
-
财政年份:2000
-
负责人:PAUL JOHN BERTICS
-
依托单位:
EFFECT OF INTERLEUKIN 5 RECEPTOR ACTIVATION ON EOSINOPHIL SIGNAL TRANSDUCTION
-
批准号:6302440
-
项目类别:
-
资助金额:$22.9万
-
财政年份:1999
-
负责人:PAUL JOHN BERTICS
-
依托单位:
IL 5 REGULATION OF EOSINOPHIL SIGNAL TRANSDUCTION AND FUNCTION
-
批准号:6201182
-
项目类别:
-
资助金额:$15.45万
-
财政年份:1999
-
负责人:PAUL JOHN BERTICS
-
依托单位:
EFFECT OF INTERLEUKIN 5 RECEPTOR ACTIVATION ON EOSINOPHIL SIGNAL TRANSDUCTION
-
批准号:6110689
-
项目类别:
-
资助金额:$22.9万
-
财政年份:1998
-
负责人:PAUL JOHN BERTICS
-
依托单位:
IL 5 REGULATION OF EOSINOPHIL SIGNAL TRANSDUCTION AND FUNCTION
-
批准号:6099725
-
项目类别:
-
资助金额:$15.45万
-
财政年份:1998
-
负责人:PAUL JOHN BERTICS
-
依托单位:
IL 5 REGULATION OF EOSINOPHIL SIGNAL TRANSDUCTION AND FUNCTION
-
批准号:6235187
-
项目类别:
-
资助金额:$17.5万
-
财政年份:1997
-
负责人:PAUL JOHN BERTICS
-
依托单位:
EFFECT OF INTERLEUKIN 5 RECEPTOR ACTIVATION ON EOSINOPHIL SIGNAL TRANSDUCTION
-
批准号:6273183
-
项目类别:
-
资助金额:$22.41万
-
财政年份:1997
-
负责人:PAUL JOHN BERTICS
-
依托单位:
EFFECT OF INTERLEUKIN 5 RECEPTOR ACTIVATION ON EOSINOPHIL SIGNAL TRANSDUCTION
-
批准号:6242683
-
项目类别:
-
资助金额:$21.78万
-
财政年份:1996
-
负责人:PAUL JOHN BERTICS
-
依托单位:
EGF RECEPTOR FUNCTION AND CONTROL BY PHOSPHORYLATION
-
批准号:2092768
-
项目类别:
-
资助金额:$12.13万
-
财政年份:1988
-
负责人:PAUL JOHN BERTICS
-
依托单位:
EGF RECEPTOR FUNCTION AND CONTROL BY PHOSPHORYLATION
-
批准号:3191707
-
项目类别:
-
资助金额:$7.93万
-
财政年份:1988
-
负责人:PAUL JOHN BERTICS
-
依托单位:
EGF RECEPTOR FUNCTION AND CONTROL BY PHOSPHORYLATION
-
批准号:3191704
-
项目类别:
-
资助金额:$7.78万
-
财政年份:1988
-
负责人:PAUL JOHN BERTICS
-
依托单位:
EGF RECEPTOR FUNCTION AND CONTROL BY PHOSPHORYLATION
-
批准号:2192614
-
项目类别:
-
资助金额:$14.66万
-
财政年份:1988
-
负责人:PAUL JOHN BERTICS
-
依托单位:
海外基金